Detalles de la búsqueda
1.
Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy.
BJU Int
; 133 Suppl 4: 14-22, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37858931
2.
Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery-outcomes from an international multidisciplinary panel.
Eur J Nucl Med Mol Imaging
; 2023 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38012448
3.
Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?
BJU Int
; 131(1): 20-31, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36083229
4.
Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancer.
BJU Int
; 131 Suppl 4: 14-22, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36594205
5.
Median 5-year outcomes of primary focal irreversible electroporation for localised prostate cancer.
BJU Int
; 131 Suppl 4: 6-13, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36495481
6.
Salvage irreversible electroporation for radio-recurrent prostate cancer - the prospective FIRE trial.
BJU Int
; 131 Suppl 4: 23-31, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36495482
7.
Using prostate-specific membrane antigen positron-emission tomography to guide prostate biopsies and stage men at high-risk of prostate cancer.
BJU Int
; 132(6): 705-712, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37620288
8.
The relationship between biochemical recurrence and number of lymph nodes removed during surgery for localized prostate cancer.
BMC Urol
; 23(1): 68, 2023 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37118731
9.
Final Analysis of the Magnetic Resonance Imaging in Active Surveillance Trial.
J Urol
; 208(5): 1028-1036, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35947521
10.
Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer.
BJU Int
; 130(5): 611-618, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35474600
11.
Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes.
BMC Urol
; 22(1): 28, 2022 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35236338
12.
Focal ablation of apical prostate cancer lesions with irreversible electroporation (IRE).
World J Urol
; 39(4): 1107-1114, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32488359
13.
The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies.
J Urol
; 203(5): 910-917, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31825297
14.
Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment.
BJU Int
; 125(3): 369-378, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31725935
15.
Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer.
BJU Int
; 125(4): 515-524, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31957122
16.
Electronic health record and research; happy marriage or early divorce?
BJU Int
; 133 Suppl 3: 75, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37804138
17.
Reply to 'Re: Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy'.
BJU Int
; 133 Suppl 4: 25-26, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38419354
18.
Diagnostic accuracy of 68 Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of 68 Ga-PSMA PET to mpMRI.
BJU Int
; 124 Suppl 1: 42-49, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31287613
19.
Prostate cancer in 432 men aged <50 years in the prostate-specific antigen era: a new outlook.
BJU Int
; 122 Suppl 5: 35-41, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30303599
20.
Focal irreversible electroporation as primary treatment for localized prostate cancer.
BJU Int
; 121(5): 716-724, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28796935